Vertex Pharmaceuticals (VRTX) Earnings Date, Estimates & Call Transcripts → Pentagon contract could send this $2 AI stock soaring (From Behind the Markets) (Ad) Free vrtx Stock Alerts $400.76 -4.15 (-1.02%) (As of 04/24/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Earnings SummaryUpcoming Earnings DateMay. 6After Market ClosesConfirmedActual EPS (Feb. 5) $4.20 Beat By $0.35 Consensus EPS (Feb. 5) $3.85 Read Call TranscriptListen to Call Get Vertex Pharmaceuticals Earnings AlertsEnter your email address below to receive the latest news and earnings results for VRTX and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueVRTX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.VRTX Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Behind the MarketsPentagon contract could send this $2 AI stock soaringWhenever the Department of Defense awards a major AI contract... Early investors could see dramatic returns virtually overnight. That's how my readers were able to cash in gains like 133% in just four months on C3.ai...Get all the info here >>> Vertex Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20242$3.56$3.73$3.65 Q2 20242$3.57$3.81$3.69 Q3 20242$3.56$3.68$3.62 Q4 20242$3.67$4.08$3.88 FY 20248$14.36$15.30$14.83 Q1 20251$3.52$3.52$3.52 Q2 20251$3.73$3.73$3.73 Q3 20251$3.74$3.74$3.74 Q4 20251$3.82$3.82$3.82 FY 20254$14.81$14.81$14.81 Q1 20261$3.77$3.77$3.77 VRTX Earnings Date and InformationVertex Pharmaceuticals last released its earnings data on February 5th, 2024. The pharmaceutical company reported $4.20 EPS for the quarter, beating analysts' consensus estimates of $3.85 by $0.35. The firm earned $2.52 billion during the quarter, compared to the consensus estimate of $2.50 billion. Vertex Pharmaceuticals has generated $13.89 earnings per share over the last year ($13.89 diluted earnings per share) and currently has a price-to-earnings ratio of 28.8. Earnings for Vertex Pharmaceuticals are expected to grow by 7.96% in the coming year, from $14.95 to $16.14 per share. Vertex Pharmaceuticals has confirmed that its next quarterly earnings report will be published on Monday, May 6th, 2024. Vertex Pharmaceuticals will be holding an earnings conference call on Monday, May 6th at 4:30 PM Eastern. Interested parties can register for or listen to the call.. Read More Vertex Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 5/6/2024Confirmed)------- 2/5/2024Q4 2023$3.85$4.20+$0.35$3.43$2.50 billion$2.52 billion 11/6/2023Q3 2023$3.53$4.08+$0.55$3.37$2.50 billion$2.48 billion 8/1/2023Q2 2023$3.47$3.53+$0.06$3.54$2.41 billion$2.49 billion5/1/2023Q1 2023$2.51$3.05+$0.54$2.65$2.34 billion$2.37 billion 2/7/2023Q4 2022$3.11$3.76+$0.65$3.51$2.30 billion$2.30 billion 10/27/2022Q3 2022$3.31$3.62+$0.31$3.65$2.23 billion$2.33 billion Get the Latest News and Ratings for VRTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Vertex Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 8/4/2022Q2 2022$3.05$3.25+$0.20$3.37$2.13 billion$2.20 billion 5/5/2022Q1 2022$3.17$3.16($0.01)$3.36$2.07 billion$2.10 billion 1/26/2022Q4 2021$2.91$3.18+$0.27$3.36$1.99 billion$2.07 billion 11/2/2021Q3 2021$2.74$3.56+$0.82$3.22$1.85 billion$1.98 billion 7/29/2021Q2 2021$2.25$3.11+$0.86$5.34$1.71 billion$1.79 billion 4/29/2021Q1 2021$2.38$2.98+$0.60$2.59$1.66 billion$1.72 billion Vertex Pharmaceuticals Earnings - Frequently Asked Questions When is Vertex Pharmaceuticals's earnings date? Vertex Pharmaceuticals has confirmed that its next quarterly earnings data will be published on Monday, May 6th, 2024. Learn more on VRTX's earnings history. Did Vertex Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Vertex Pharmaceuticals (NASDAQ:VRTX) reported $4.20 earnings per share (EPS) to beat the analysts' consensus estimate of $3.85 by $0.35. Learn more on analysts' earnings estimate vs. VRTX's actual earnings. How can I listen to Vertex Pharmaceuticals's earnings conference call? The conference call for Vertex Pharmaceuticals's latest earnings report can be listened to online. Listen to Conference Call How can I read Vertex Pharmaceuticals's conference call transcript? The conference call transcript for Vertex Pharmaceuticals's latest earnings report can be read online. Read Transcript How much revenue does Vertex Pharmaceuticals generate each year? Vertex Pharmaceuticals (NASDAQ:VRTX) has a recorded annual revenue of $9.87 billion. How much profit does Vertex Pharmaceuticals generate each year? Vertex Pharmaceuticals (NASDAQ:VRTX) has a recorded net income of $3.62 billion. VRTX has generated $13.89 earnings per share over the last four quarters. What is Vertex Pharmaceuticals's price-to-earnings ratio? Vertex Pharmaceuticals (NASDAQ:VRTX) has a trailing price-to-earnings ratio of 28.84 and a forward price-to-earnings ratio of 26.80. The price/earnings-to-growth ratio is 1.88. What is Vertex Pharmaceuticals's EPS forecast for next year? Vertex Pharmaceuticals's earnings are expected to grow from $14.95 per share to $16.14 per share in the next year, which is a 7.96% increase. More Earnings Resources from MarketBeat Related Companies: REGN Earnings Results BMY Earnings Results SNY Earnings Results GSK Earnings Results ZTS Earnings Results PFE Earnings Results TAK Earnings Results RPRX Earnings Results ABT Earnings Results BGNE Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future OutlookCSX Co.: The Railroad Powering Ahead with an Earnings Beat What's Driving Tesla Lower Ahead of its Earnings?Blackrock vs. State Street: Earnings in a Volatile MarketWhat to Expect From the Q1 Earnings Reporting SeasonLululemon Stock Implodes Post Earnings, Guidance Muted This page (NASDAQ:VRTX) was last updated on 4/24/2024 by MarketBeat.com Staff From Our Partnerstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyPentagon contract could send this $2 AI stock soaringBehind the MarketsDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsFed launches fourth dollar overhaulStansberry ResearchNew Trump BombshellThe Freeport SocietyThe Greatest Bull Market in Crypto History…Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vertex Pharmaceuticals Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
